2014•New England Journal of MedicineRequires access

Drug Development and FDA Approval, 1938–2013

Jonathan J. Darrow, Aaron Seth Kesselheim

Open publisher page 45 citations

Abstract

This interactive graphic shows major legislative and regulatory events related to approval of new drugs by the Food and Drug Administration (FDA), drug approvals by year and by therapeutic category, and trends in the use of the FDA's various programs for expedited approval.

About this research paper

What this paper is about

This interactive graphic shows major legislative and regulatory events related to approval of new drugs by the Food and Drug Administration (FDA), drug approvals by year and by therapeutic category, and trends in the use of the FDA's various programs for expedited approval.

Why it matters

OpenAlex reports 45 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This interactive graphic shows major legislative and regulatory events related to approval of new drugs by the Food and Drug Administration (FDA), drug approvals by year and by therapeutic category, and trends in the use of the FDA's various programs for expedited approval.

Key concepts: Medicine, Food and drug administration, Drug approval, Drug, Approved drug, Drug development, Clinical research, Legislature

Related papers

Back to paper searchBrowse research topicsOriginal source
Drug Development and FDA Approval, 1938–2013 — Research Paper | ScholarLens